Offer - Urjas Oil for just ₹ 1 X
Clonaxyl 0.5 Mg Tablet is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
13 - 18 years (Adolescent) |
|
2 - 12 years (Child) |
|
Is the use of Clonaxyl 0.5 Mg Tablet safe for pregnant women?
Clonaxyl may cause moderate side effects during pregnancy. If you feel its harmful effects, then stop taking this drug immediately, and do not take Clonaxyl again without your doctor's advice.
Is the use of Clonaxyl 0.5 Mg Tablet safe during breastfeeding?
Breastfeeding women may feel side effects of Clonaxyl. If you see any side effects, stop taking Clonaxyl immediately and talk to your doctor. Take Clonaxyl again, only after your doctor's advice.
What is the effect of Clonaxyl 0.5 Mg Tablet on the Kidneys?
Clonaxyl may have mild side effects on the kidneys.
What is the effect of Clonaxyl 0.5 Mg Tablet on the Liver?
Clonaxyl has very mild side effects on the liver.
What is the effect of Clonaxyl 0.5 Mg Tablet on the Heart?
Using Clonaxyl does not have any harmful effects on the heart.
Clonaxyl 0.5 Mg Tablet should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Clonaxyl 0.5 Mg Tablet unless your doctor advises you to do so -
Is this Clonaxyl 0.5 Mg Tablet habit forming or addictive?
Clonaxyl 0.5 Mg Tablet can be addictive. You should not take it without medical advice.
Is it safe to drive or operate heavy machinery when consuming?
After taking Clonaxyl 0.5 Mg Tablet, you should not drive or work on any heavy machine, as Clonaxyl 0.5 Mg Tablet can make you drowsy.
Is it safe?
Yes, Clonaxyl 0.5 Mg Tablet is safe but you must consult your doctor before taking it.
Is it able to treat mental disorders?
Yes, taking Clonaxyl 0.5 Mg Tablet can treat mental disorders.
Interaction between Food and Clonaxyl 0.5 Mg Tablet
Clonaxyl 0.5 Mg Tablet may take longer to act if you eat some foods while taking it. Follow your doctor's advice on this.
Interaction between Alcohol and Clonaxyl 0.5 Mg Tablet
Consult your doctor before consuming alcohol while taking Clonaxyl 0.5 Mg Tablet as it can have severe side effects.
Yes, Clonaxyl causes drowsiness, dizziness or sedation. It is one of the most common side effects of this medicine. Do not drive vehicle or operate machinery after taking this medicine.
Clonaxyl works by relaxing the muscles of the body and suppressing abnormal activity of nerve cells in the brain through an increase in activity of a chemical messenger known as GABA. Thus, providing relief from sleeplessness and anxiety to the patient.
Yes, it can lower the heart rate but this occurs rarely. The exact cause behind this is unknown. If you are experiencing low heart rate after taking this drug, consult your doctor immediately without any further delay.
No, Clonaxyl does not cause low blood pressure at regular doses. However, it may cause low blood pressure if it is taken in higher doses. If you are experiencing low blood pressure after taking this drug, then please consult your doctor immediately without any further delay.
Yes, use of Clonaxyl for short-term can help in providing relief from anxiety through relaxing the muscles of the body and suppressing abnormal activity of nerve cells in the brain.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Klonopin (clonazepam)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 418
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 330-332